RUNX3 and poikiloderma with neutropenia: The analysis of RUNX3 and RASSF1A promoter methylation on biopsy and serum-derived samples might be another interesting approach to distinguish between benign and malignant PN, as solitary PN ≤10 mm in size were included in this study [110].